Showing 1491-1500 of 1746 results for "".
- iSTAR Medical Presents Positive Results for MINIject Across Three International Glaucoma Trialshttps://modernod.com/news/istar-medical-presents-positive-results-for-miniject-across-three-international-glaucoma-trials/2480908/iSTAR Medical presented 2-year safety and efficacy results in a meta-analysis of its STAR-I, STAR-II and STAR-III clinical trials for
- Xiidra Approved by Health Canada To Treat the Signs and Symptoms of Dry Eye Diseasehttps://modernod.com/news/xiidra-approved-by-health-canada-to-treat-the-signs-and-symptoms-of-dry-eye-disease/2480273/Shire announced that »Xiidra (lifitegrast ophthalmic solution 5%), a twice-daily eye drop solution indicated for the treatment of the signs and symptoms of dry eye disease i
- SECO International Names Dr. R. Max Raynor as 2021 Presidenthttps://modernod.com/news/seco-international-names-dr-r-max-raynor-as-2021-president/2477497/SECO International has named R. Max Raynor, OD, as the next president. His term began on March 7, 2020, and will last through February 28, 2021. Dr. Raynor officially accepted the honor during the House of Delegates meeting held on Saturday, March 7 at SECO 20/20. “Dr. Raynor has dedicated
- Eli Lilly Enters Ophthalmology Sector with Acquisition of Adverum Biotechnologieshttps://modernod.com/news/eli-lilly-enters-ophthalmology-sector-with-acquisition-of-adverum-biotechnologies/2484212/Eli Lilly and Company and Adverum Biotechnologies announced that they have entered into a definitive agreement for Lilly to acquire Adverum Biotechnologies, including its lead gene therapy product candidate, Ixo-vec. I
- Medicel Unveils Environmentally Friendly Terralution Rangehttps://modernod.com/news/medicel-unveils-environmentally-friendly-terralution-range-at-escrs/2482428/At the European Society of Cataract & Refractive Surgeons (ESCRS) Congress in Barcelona, Medicel will launch of its terralution product family, which consists of single-use injectors and I/A handp
- Research Challenges “Sugar Hypothesis” of Diabetic Cataract Developmenthttps://modernod.com/news/research-challenges-sugar-hypothesis-of-diabetic-cataract-development/2481371/New findings from investigators at Brigham and Women’s Hospital, a founding member of the Mass General Brigham health care system, contradict previous notions about sugar’s role i
- ASCRS: Insurance Company Policy Delays Sight-Restoring Surgery, Puts Patients in Jeopardyhttps://modernod.com/news/ascrs-insurance-company-policy-delays-sight-restoring-surgery-puts-patients-in-jeopardy/2479334/The decision by Aetna to require preauthorization of all cataract surgery procedures went into effect July 1. In a news release, ASCRS said it is opposed to the preauthorization policy, stating it will create delays i
- Wolfe Eye Clinic Performs First Surgery in Clinical Trial Evaluating an Investigational Gene Therapy for Geographic Atrophy Secondary to Dry AMDhttps://modernod.com/news/wolfe-eye-clinic-performs-first-surgery-in-clinical-trial-evaluating-an-investigational-gene-therapy-for-geographic-atrophy-secondary-to-dry-amd/2478676/Wolfe Eye Clinic announced today that Jared Nielsen, MD, Retina Disease Specialist at Wolfe Eye Clinic, was recently the third surgeon in the United States and first in the Midwest to perform surgery in a clinic trial evaluating an i
- Nicox Partners Zerviate in the Gulf and Arab Marketshttps://modernod.com/news/nicox-partners-zerviate-in-the-gulf-and-arab-markets/2478152/Nicox SA announced the signature of an exclusive license agreement with Itrom Pharmaceutical Group for the registration and commercialization of Zerviate (cetirizine ophthalmic solution), 0.24% for the treatment of ocular itching associated with allergic conjunctivitis in Gulf and Arab markets. I
- Methotrexate Treat-and-Extend Tested for Vitreoretinopathyhttps://modernod.com/news/methotrexate-treat-and-extend-tested-for-vitreoretinopathy/2478096/A treat-and-extend regimen of methotrexate can be used to successfully treat proliferative vitreoretinopathy, according to a series of 50 eyes in which 96% of retinas were successfully reattached, Medscape reported. “I’
